Invited commentary.
Merry
Alan F
AF
Department of Anesthesiology, University of Auckland, Private Bag 92019, Auckland, New Zealand 1003. a.merry@auckland.ac.nz
D000906:Antibodies / Q000097:blood*; D000925:Anticoagulants / Q000627:therapeutic use*; D047549:Coronary Artery Bypass, Off-Pump / Q000379:methods*; D006493:Heparin / Q000009:adverse effects*; D006629:Hirudins; D006801:Humans; D010446:Peptide Fragments / Q000627:therapeutic use*; D010978:Platelet Factor 4 / Q000276:immunology*; D011994:Recombinant Proteins / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000139:chemically induced*
D000906:Antibodies; D000925:Anticoagulants; D006629:Hirudins; D010446:Peptide Fragments; D011994:Recombinant Proteins; D010978:Platelet Factor 4; D006493:Heparin; C074619:bivalirudin